Picture of Collplant Biotechnologies logo

CLGN — Collplant Biotechnologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Develop 3D Bioprinted Human Intestine Model For Drug Discovery

Nov 15 (Reuters) - Collplant Biotechnologies Ltd
 CPTG.F :
    * COLLPLANT, TEL AVIV UNIVERSITY AND SHEBA MEDICAL CENTER
JOIN
FORCES TO CO-DEVELOP RHCOLLAGEN-BASED 3D BIOPRINTED HUMAN
INTESTINE MODEL FOR DRUG DISCOVERY AND PERSONALIZED TREATMENT OF
ULCERATIVE COLITIS
    * COLLPLANT BIOTECHNOLOGIES - CO TO FUND DEVELOPMENT AND
RECEIVE
EXCLUSIVE LICENSE TO MANUFACTURE AND COMMERCIALIZE HUMAN
INTESTINE TISSUE MODEL

Source text for Eikon:  ID:nPn40Kpg2a 
Further company coverage:  CPTG.F 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Collplant Biotechnologies

See all news